[Abstract] The discovery of endothelial colony forming cells (ECFCs) with robust self-renewal and de novo vessel formation potentials suggests that ECFCs can be an excellent cell source for cardiovascular diseases treatment through improving neovascularization in the ischemic tissues. However, their engraftment after transplantation resulted to be low. Previous studies showed mesenchymal stem/stromal cells (MSCs) could improve the survival and capillary formation capacity of ECFCs in coculture systems. In this article, we describe a protocol for in vitro co-culture of MSCs and ECFCs to prime ECFCs for better engraftment.
2. Human ECFCs: Human fetal placental ECFCs were isolated as reported previously (Patel et al., 2013) . To distinguish between MSCs and ECFCs after co-culture, we suggest using GFP tagged ECFCs as used in the current protocol but non-GFP tagged cells can also be used 
Note: Sorted cells in PBS (or PBS with BSA/FBS) have limited viability, so sorting in FBS is
recommended.
5. These cells can be then subjected to tube-formation assay, limiting dilution assay and gene expression analysis. For the tube-formation assay, we counted capillary-like structures in at least 20 fields of view.
2. All Statistical analysis can be performed using GraphPad Prism 7 software. Paired or unpaired Student's t-test can be used to determine statistical differences among different groups.
Notes
1. For better functionality and reproducibility of the results, we recommend using stem/progenitor cells at passages 3-5 for all the experiments.
2. FACS solutions, culture media, immunostaining solutions need to be prepared on the day of use for best results.
3. All cell culture reagents should be warmed at 37 °C before use.
4. For highest viability during the FACS sorting, cells should be kept on ice. 
